|
1
|
Daytime and nighttime differences in patterns of performance of primary angioplasty in the treatment of patients with acute myocardial infarction. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group.
|
Am Heart J
|
1999
|
1.66
|
|
2
|
The safety and efficacy of an extravascular, water-soluble sealant for vascular closure: initial clinical results for Mynx.
|
Catheter Cardiovasc Interv
|
2007
|
1.63
|
|
3
|
Spectrum of reperfusion strategies and factors influencing the use of primary angioplasty in patients with acute myocardial infarction admitted to hospitals with the facilities to perform primary angioplasty. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group.
|
Heart
|
1999
|
1.39
|
|
4
|
Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group.
|
Catheter Cardiovasc Interv
|
1999
|
1.39
|
|
5
|
Multicenter evaluation of a self-expanding carotid stent system with distal protection in the treatment of carotid stenosis.
|
AJNR Am J Neuroradiol
|
2006
|
0.84
|
|
6
|
Volume-outcome relation for contemporary percutaneous coronary interventions (PCI) in daily clinical practice: is it limited to high-risk patients? Results from the Registry of Percutaneous Coronary Interventions of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK).
|
Heart
|
2007
|
0.82
|
|
7
|
Glycoprotein IIb/IIIa antagonists during carotid artery stenting: results from the carotid artery stenting (CAS) registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK).
|
Clin Res Cardiol
|
2007
|
0.80
|
|
8
|
Carotid artery stenting in clinical practice results from the Carotid Artery Stenting (CAS)-registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK).
|
Z Kardiol
|
2005
|
0.78
|
|
9
|
Interventional treatment and outcome in elderly patients with stable coronary artery disease. Results from the German ALKK registry.
|
Herz
|
2013
|
0.77
|
|
10
|
Determinants of mortality after cardiac surgery: results of the registry of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK) on 10 525 patients.
|
Eur Heart J
|
2000
|
0.77
|
|
11
|
The NUGGET study: NIR ultra gold-gilded equivalency trial.
|
Catheter Cardiovasc Interv
|
2004
|
0.76
|
|
12
|
[Long-term follow-up of patients with acute myocardial infarction treated with primary angioplasty or thrombolysis. Results of the MITRA trial].
|
Z Kardiol
|
2002
|
0.76
|
|
13
|
[Primary dilatation versus thrombolysis in patients with acute myocardial infarct, not included in randomized studies. Results of the MITRA Study. Maximal Individual Optimized Therapy for Acute Myocardial Infarct].
|
Z Kardiol
|
1999
|
0.75
|
|
14
|
Primary angioplasty in acute myocardial infarction: differences between referred patients and those treated in hospitals with on-site facilities?
|
J Invasive Cardiol
|
1999
|
0.75
|
|
15
|
Impact of coronary artery disease on in-hospital mortality in patients with aortic valve disease. Results from the German ALKK registry.
|
Herz
|
2013
|
0.75
|
|
16
|
[30-day mortality after heart surgery: a pilot project of the Working Party of Directors of Hospital Cardiology Departments].
|
Dtsch Med Wochenschr
|
1999
|
0.75
|
|
17
|
Primary percutaneous transluminal coronary angioplasty for acute myocardial infarction in patients not included in randomized studies. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group.
|
Am J Cardiol
|
1999
|
0.75
|
|
18
|
Differences in patients with acute myocardial infarction treated with primary angioplasty or thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group.
|
Clin Cardiol
|
1999
|
0.75
|